- No Borders, Inc. is a technological solutions innovator dedicated to a variety of market verticals, including the buzzworthy hemp CBD products and blockchain technology sectors
- No Borders cannabidiol (CBD) products can help people addicted to painkillers or suffering from poor sleep to improve their general wellbeing
- Blockchain applications developed through No Borders’ tech labs can help ensure the quality and legality of CBD products from test to shelf, and blockchain’s worth is becoming more evident as government agencies experiment with its data-tracking capabilities
Trust and wellness provider No Borders Inc. (OTC: NBDR) inspires confidence through its diverse approach to market building, living up to its name by extending its reach to a variety of explosive growth verticals. Two of those sectors are hemp-based cannabis products and blockchain security applications, which can work together to symbiotically help consumers improve their general well-being.
Blockchain has been gaining attention for well over a decade as a device for building confidence in online transactions. Its core principle is that a finalized record of every aspect of a transaction can be created and shared among all participants in the transaction as the events occur, thereby virtually eliminating the likelihood of fraud occurring through irreconcilable alteration of a digital record.
The secure microcosm-building capacity of blockchain has gained popularity in digital currency transactions across all borders – creating the potential for a ‘No Borders’ world – and is increasingly being touted as a means of ensuring consumable products’ safety and quality. That’s where its use in the hemp derivatives market comes in – popular extracts such as cannabidiol (CBD) can be scary for consumers to try and No Borders internally built, owned and deployed blockchain PAAS, CBD LabChain provides consumers with a tangible trust layer with entries from lab tests along the road to market showcasing the product’s established quality, efficacy and THC Free compliance.
Blockchain tracking of CBD products even creates the potential of the government someday being able to establish affordable scientific testing of extracts’ qualities for the purpose of building a reliability standard the Food and Drug Administration (FDA) can turn to in questions of legalization at a federal level.
Blockchain applications began as something of an underground alternative to official processes and procedures, but government administrations are including blockchain capabilities in their thinking more and more often. An example of the sea change is shown in the announcement that the U.S. Treasury is testing a blockchain-based subsidy process designed to “make the allocation and use of funding more efficient through traceable data storage,” according to a recent report by Medium (http://cnw.fm/LbN9G).
The market’s potential to use blockchain in its production pipelines may help it prevent disasters such as the deadly Tylenol consumer poisonings nearly 40 years ago that resulted from an unknown assailant tampering with store products (http://cnw.fm/0k6Ia).
Blockchain tracking of retail products may also help ensure consumers about the quality of CBD products and thereby avoid costly problems associated with products that don’t adhere to desired standards. The Department of Defense has a zero-tolerance policy for service members who illegally or improperly use drugs, for example, which includes substances such as CBD oil.
“Even if CBD extract contains 0.3 percent or less of THC, service members put themselves at risk if they consume these products without being prescribed an [Food and Drug Administration]-approved product by a medical professional,” Air Force Capt. Marcus Walker, 436th Airlift Wing Assistant Staff Judge Advocate, told the Defense Visual Information Distribution Service (http://cnw.fm/o1E29).
“Products may contain more THC than expected and have the potential to cause a positive urine drug test and intoxication, which may affect military readiness. These products may also be adulterated with other active components, like synthetic cannabinoids, which may lead to intoxication and accidents,” Dr. Erin Karschner, Armed Forces Medical Examiner System forensic toxicologist added.
No Borders CEO Joseph Snyder is bullish about the benefits of CBD, however.
“I was introduced to CBD after spending over four years on prescription opioids for back to back shoulder surgeries, within hours I knew there was an impact and within days I knew I didn’t need the poison opioids anymore,” Snyder stated in an email to NetworkNewsWire about his recovery from a prior painkiller addiction that resulted from numerous injuries and surgeries.
“I knew we as a company and I as a human, needed to share CBD with the world,” he added. “So began No Borders Naturals, now proudly secured and certified on blockchain with our proprietary CBD LabChain.”
A separate email touts CBD’s effectiveness in helping people to overcome restless sleep patterns. Poor sleep is linked to a lack of energy and potentially to poor health (http://cnw.fm/e8lAJ).
“While researchers still don’t fully understand why CBD helps with sleep, there is a lot of convincing research out there,” the email states. “Another reason that CBD can be so helpful for sleep issues is that it can reduce discomfort caused by all sorts of conditions. Those who have arthritis or muscle aches can find it difficult to get a good night’s sleep on a regular basis.”
For more information, visit the company’s website at www.NBDR.co
NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.